DocBuzz, Inc., which specializes in medical marketing, is a company that focuses on pharmaceutical, biotechnical, and medical device details for the benefit of doctors. DocBuzz, Inc., which is owned and operated solely by physicians, is the only company its kind.

With revenue exceeding $96.3B annually, the pharmaceutical market ranks as one of the most profitable. The problem facing the pharmaceutical sector is simply time. Time for research and development, time for branding, time for marketing and sales, time to gain the trust and acceptance of the medical community. We can easily compare time and money in this industry.

Similar situations exist in two other industries that produce similar products. The biotech and medical devices industries are similar. While the revenues are not as great as what one will find within the pharmaceutical industry, these companies face heavy competition within their own individual industries.

DocBuzz, Inc., has developed a method that allows all of these industries to benefit from prelaunch marketing, product branding, and postlaunch sales support–all accomplished with the direct intervention of practicing physicians. DocBuzz, Inc. provides clients with the ability to market directly towards decision-makers, establishing credibility instantly through our extensive network and medical professionals. Providing live conferences, 24 hours a day, seven days a week, access to a myriad of current information on various pharmaceutical products, new biotech developments and medical devices, medical chat rooms, and online marketing make our e-detailing the most cost effective of any service offered.

DocBuzz, Inc. will provide marketing services to the medical device, pharmaceutical, and biotech industries. We are physicians and have access to our colleagues immediately. These companies can have their message delivered directly to decision-makers for 75% less than what they are currently budgeting. DocBuzz, Inc.’s unique incentive program will generate additional revenue for participating physicians and other doctors.

DocBuzz has developed a winning strategy to provide the best and most up to date information to the medical community, while providing a method for these industries to announce, promote and market their products through respected practicing physicians. The individual professionals within the medical community benefit by receiving the most up to date industry information, all received via the Internet, and at the end of the e-detailing they will have the option to request samples, additional information on the product and/or the visit from a pharmaceutical company representative. Professionals on our medical panel can earn points by participating in our e-detailing and/or by referral of others who join our program.

1. Keys to Success

DocBuzz, Inc., identified four key strategies that are critical to our success.

1. New Internet technology has allowed for easier access to the prescription doctor to pharmaceuticals. This will allow for faster market acceptance and a more consistent prescribing pattern.
2. DocBuzz, Inc. employs a grass roots approach to recruiting and retaining participating prescribing doctors through a value incentivised referral program (VIRP). DocBuzz, Inc. is a physician-owned and operated business. We understand physician needs and offer, along with our unique VIRP system, additional value added programs like CME, physician cyber meetings places, and other point redemption options.
3. DocBuzz, Inc. provides evidence-based analysis to the pharmaceutical industry to support the investment in e–detail.
4. DocBuzz, Inc., believes in controlled, aggressive growth, to ensure the quality and safety of our service.

1.2 Mission

DocBuzz, Inc., is a reliable, high-quality option to in-house resources. DocBuzz, Inc., improves the return on sales and marketing investment by accelerating the physician learning curve on prelaunch, new, and existing products–through Web access to educational detailing and marketing research. DocBuzz, Inc., also benefits small, innovative biotechnology and pharmaceutical businesses that do not have a strong North American sales force.

1.3 Objectives